Department of Cardiology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Department of Neurology, Alpert Medical School of Brown University, Providence, RI 02903, USA.
Tomography. 2024 Oct 14;10(10):1694-1705. doi: 10.3390/tomography10100124.
: Left ventricular diastolic dysfunction (LVDD) and elevated left ventricular filling pressure (LVFP) are strong predictors of clinical outcomes across various populations. However, their diagnostic utility in embolic stroke of undetermined source (ESUS) remains unclear. We hypothesized that LVDD with elevated LVFP (based on echocardiography) was more likely to be prevalent in ESUS compared to non-cardioembolic stroke (NCE) and to be associated with atrial fibrillation (AF) on follow-up monitoring. : This is a single-center retrospective study that included adult patients with a diagnosis of acute ischemic stroke between January 2016 and June 2017. LV function was assessed by inpatient transthoracic echocardiogram (TTE), and stroke etiology was adjudicated by the neurologist per the consensus criteria. Patients with cardioembolic stroke and those with indeterminate diastolic function on TTE were excluded. Baseline patient characteristics and clinical variables were compared among patients with and without LVDD and elevated LVFP. Multivariable regression models were used to assess the associations between diastolic dysfunction, ESUS, and AF detection in ESUS patients. : We identified 509 patients with ESUS and NCE stroke who had reported diastolic function. The mean age was 64.19 years, 45.19% were female, and 146 had LVDD with available LVFP data. LVDD was not associated with ESUS (adjusted OR: 1.43, 95% CI: 0.90-2.27, = 0.130) or atrial fibrillation (AF) detection on cardiac monitoring (adjusted OR: 1.88, 95% CI: 0.75-4.72, = 0.179). However, LVDD with elevated LVFP was borderline associated with ESUS (adjusted OR: 2.17, 95% CI: 0.99-4.77, = 0.054) and significantly associated with AF detection (adjusted OR: 3.59, 95% CI: 1.07-12.06, = 0.038). : Our data suggest that LVDD with elevated LVFP is borderline associated with ESUS and significantly associated with AF detection on follow-up cardiac monitoring. Therefore, the presence of LVDD with an increased probability of elevated LVFP may help identify a subset of stroke patients more likely to have ESUS, potentially due to atrial cardiopathy with underlying occult AF. Further studies are needed to confirm our findings and to evaluate the safety and efficacy of anticoagulation in patients with ESUS and LVDD with elevated LVFP.
左心室舒张功能障碍(LVDD)和左心室充盈压升高(LVFP)是各种人群临床结局的强有力预测因子。然而,它们在不明来源栓塞性卒中(ESUS)中的诊断效用仍不清楚。我们假设,与非心源性卒中和(NCE)相比,LVDD 伴 LVFP 升高(基于超声心动图)更常见,并与随访监测中的心房颤动(AF)相关。
这是一项单中心回顾性研究,纳入了 2016 年 1 月至 2017 年 6 月期间诊断为急性缺血性卒中的成年患者。LV 功能通过住院期间的经胸超声心动图(TTE)评估,卒中病因由神经病学家根据共识标准进行判定。排除了心源性卒中和 TTE 不确定舒张功能的患者。比较了伴有和不伴有 LVDD 和 LVFP 升高的患者的基线患者特征和临床变量。多变量回归模型用于评估舒张功能障碍、ESUS 和 ESUS 患者 AF 检测之间的关联。
我们确定了 509 例 ESUS 和 NCE 卒中患者,他们报告了舒张功能。平均年龄为 64.19 岁,45.19%为女性,146 例伴有 LVDD 和可用的 LVFP 数据。LVDD 与 ESUS 无关(调整后的比值比:1.43,95%可信区间:0.90-2.27,=0.130)或心脏监测时的心房颤动(AF)检测无关(调整后的比值比:1.88,95%可信区间:0.75-4.72,=0.179)。然而,LVDD 伴 LVFP 升高与 ESUS 呈边缘相关(调整后的比值比:2.17,95%可信区间:0.99-4.77,=0.054),与 AF 检测显著相关(调整后的比值比:3.59,95%可信区间:1.07-12.06,=0.038)。
我们的数据表明,LVDD 伴 LVFP 升高与 ESUS 呈边缘相关,与随访心脏监测时的 AF 检测显著相关。因此,LVDD 伴 LVFP 升高的存在可能有助于识别更有可能发生 ESUS 的卒中患者亚组,这可能是由于潜在隐匿性 AF 的心房心肌病所致。需要进一步研究来证实我们的发现,并评估抗凝治疗在 ESUS 伴 LVDD 伴 LVFP 升高患者中的安全性和有效性。